| 101/399 | US=6 / Quimioterapia Airley R. Inhibitors of the AKT/PKB pathway. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 229-31. ISBN 978-0-470-09254-5. |
| 102/399 | US=6 / Quimioterapia Airley R. Targeting stress proteins: HSP90 inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 233-6. ISBN 978-0-470-09254-5. |
| 103/399 | US=6 / Quimioterapia Airley R. The proteasome. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 237-43. ISBN 978-0-470-09254-5. |
| 104/399 | US=6 / Quimioterapia Airley R. Checkpoint protein kinases as novel targets - mammalian target of rapamycin (mTOR). In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 245-8. ISBN 978-0-470-09254-5. CHECKPOINT; PROTEINAS QUINASES; MTOR; ALVO DA RAPAMICINA EM MAMIFEROS; ATIVACAO DE MTOR; ANTICANCERIGENOS ALVO MTOR |
| 105/399 | US=6 / Quimioterapia Airley R. Telomerase. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 249-54. ISBN 978-0-470-09254-5. |
| 106/399 | US=6 / Quimioterapia Airley R. Histone deacetylase: an epigenetic drug target. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 255-63. ISBN 978-0-470-09254-5. INIBIDORES DE HDAC; HISTONA DEACETILASE; DROGA EPIGENETICA; HDAC; EMBALAGEM DE DNA |
| 107/399 | US=6 / Quimioterapia Airley R. Pharmaceutical problems in cancer chemotherapy. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 265-80. ISBN 978-0-470-09254-5. PROBLEMAS FARMACEUTICOS EM QUIMIOTERAPIA; MANIFESTACAO DE TOXICIDADE; REGIME DE TOXICIDADE; RESISTENCIA A DROGAS; COMPLICACOES FARMACEUTICAS |
| 108/399 | US=6 / Quimioterapia Airley R. Oncology pharmacy at home and abroad. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 281-2. ISBN 978-0-470-09254-5. |
| 109/399 | US=6 / Quimioterapia Airley R. Practice exam questions. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 283-98. ISBN 978-0-470-09254-5. |
| 110/399 | US=27 / Fisioterapia Makker V, Spriggs D. Principles of chemotherapy. In: Stubblefield MD, O'Dell MW. Cancer rehabilitation: principles and practice. New York: DemosMedical, 2009. p. 23-52. ISBN 978-19-338643-34. PRINCIPIOS DA QUIMIOTERAPIA; CARDIOMIOPATIA; COMPLICACOES VASCULARES; TOXICIDADE PULMONAR; NEUROTOXICIDADE; NEFROTOXICIDADE; TOXICIDADE AUTO-IMUNE; TOXICIDADE REUMATICA |
| 111/399 | US=60 / Biol/Mol Karna P, Yang L. Apoptotic signaling pathway and resistance to apoptosis in breast cancer stem cells. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 1-23. ISBN 978-1-4020-9596-2. RESISTENCIA A APOPTOSE; CELULAS TRONCO EM NEOPLASIAS DE MAMA; TERAPIA DE ALVO MOLECULAR; VIA APOPTOTICA; MECANISMOS DE RESISTENCIA A APOPTOSE |
| 112/399 | US=60 / Biol/Mol Karam JA, Hsieh JT. Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 25-50. ISBN 978-1-4020-9596-2. APOPTOSE; AUTOFAGIA; CANCER DE BEXIGA; NECROSE; MORTE CELULAR PROGRAMADA; VIAS DE SINALIZACAO |
| 113/399 | US=60 / Biol/Mol Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV) |
| 114/399 | US=60 / Biol/Mol Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA |
| 115/399 | US=60 / Biol/Mol Nicholl MB, Hoon DSB. Apoptosis in cutaneous melanoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 111-25. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; MELANOMA CUTANEO; APAF-1; SURVIVINA; INIBIDORES DE APOPTOSE |
| 116/399 | US=60 / Biol/Mol Li Y, Martin RCG. Apoptosis in carcinogenesis and chemotherapy - esophageal cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 127-56. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; QUIMIOTERAPIA; CANCER DE ESOFAGO; VIAS DE SINALIZACAO; CARCINOMA ESOFAGICO; ADENOCARCINOMA ESOFAGICO |
| 117/399 | US=60 / Biol/Mol Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS |
| 118/399 | US=60 / Biol/Mol Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR |
| 119/399 | US=60 / Biol/Mol Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE |
| 120/399 | US=60 / Biol/Mol Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA |